HEMOGLOBIN A(2) COBURG

MedGen UID:: 856102
•Concept ID:: C3891923
•: Finding

OMIM®:

142000

Recent clinical studies

Etiology

Not All Type-2-Diabetes Patients Increase Body Mass Index After Initiating Insulin: Results of Latent Class Analysis from the DPV Registry.

Prinz N, Schwandt A, Borgert B, Hartmann B, Kempe HP, Mader JK, Merger S, Weber-Lauffer R, Wosch FJ, Holl RW
Diabetes Technol Ther 2021 Dec;23(12):799-806. doi: 10.1089/dia.2021.0144. PMID: 34524021

Comparing diabetes due to diseases of the exocrine pancreas to type 1 and type 2 diabetes using propensity score matching.

Lanzinger S, Karges W, Merger S, Laimer M, Lück U, Wagner C, Milek K, Holl RW; DPV Initiative
Pancreatology 2020 Jul;20(5):860-866. Epub 2020 Jun 17 doi: 10.1016/j.pan.2020.05.023. PMID: 32620406

Real-life experience of patients starting insulin degludec. A multicenter analysis of 1064 subjects from the German/Austrian DPV registry.

Bohn B, Zimmermann A, Wagner C, Merger S, Dunstheimer D, Kopp F, Gollisch K, Zindel V, Holl RW; DPV Initiative
Diabetes Res Clin Pract 2017 Jul;129:52-58. Epub 2017 May 4 doi: 10.1016/j.diabres.2017.03.031. PMID: 28505544

Molecular Characterization of δ-Thalassemia in Iran.

Kordafshari A, Amirian A, Zeinali S, Valaei A, Maryami F, Karimipoor M
Hemoglobin 2016;40(1):44-7. doi: 10.3109/03630269.2015.1092982. PMID: 26754299

See all (4)

Diagnosis

Not All Type-2-Diabetes Patients Increase Body Mass Index After Initiating Insulin: Results of Latent Class Analysis from the DPV Registry.

Prinz N, Schwandt A, Borgert B, Hartmann B, Kempe HP, Mader JK, Merger S, Weber-Lauffer R, Wosch FJ, Holl RW
Diabetes Technol Ther 2021 Dec;23(12):799-806. doi: 10.1089/dia.2021.0144. PMID: 34524021

See all (1)

Therapy

Not All Type-2-Diabetes Patients Increase Body Mass Index After Initiating Insulin: Results of Latent Class Analysis from the DPV Registry.

Prinz N, Schwandt A, Borgert B, Hartmann B, Kempe HP, Mader JK, Merger S, Weber-Lauffer R, Wosch FJ, Holl RW
Diabetes Technol Ther 2021 Dec;23(12):799-806. doi: 10.1089/dia.2021.0144. PMID: 34524021

Comparing diabetes due to diseases of the exocrine pancreas to type 1 and type 2 diabetes using propensity score matching.

Lanzinger S, Karges W, Merger S, Laimer M, Lück U, Wagner C, Milek K, Holl RW; DPV Initiative
Pancreatology 2020 Jul;20(5):860-866. Epub 2020 Jun 17 doi: 10.1016/j.pan.2020.05.023. PMID: 32620406

Real-life experience of patients starting insulin degludec. A multicenter analysis of 1064 subjects from the German/Austrian DPV registry.

See all (3)

Prognosis

Real-life experience of patients starting insulin degludec. A multicenter analysis of 1064 subjects from the German/Austrian DPV registry.

See all (1)

Clinical prediction guides

Comparing diabetes due to diseases of the exocrine pancreas to type 1 and type 2 diabetes using propensity score matching.

Lanzinger S, Karges W, Merger S, Laimer M, Lück U, Wagner C, Milek K, Holl RW; DPV Initiative
Pancreatology 2020 Jul;20(5):860-866. Epub 2020 Jun 17 doi: 10.1016/j.pan.2020.05.023. PMID: 32620406

Real-life experience of patients starting insulin degludec. A multicenter analysis of 1064 subjects from the German/Austrian DPV registry.

See all (2)

MedGen

National Center for Biotechnology Information

Send to:

HEMOGLOBIN A(2) COBURG

Recent clinical studies

Etiology

Diagnosis

Therapy

Prognosis

Clinical prediction guides

Supplemental Content

Table of contents

Related information

Recent activity